Section 4: Specialty Stewardship (Faculty)
The content within Section 4 is used to educate the steward - in - training on the ways that antimicrobial stewardship varies in special settings and populations, as well as describe systematic approaches to improving antimicrobial use in the major “infection syndromes” where antimicrobials are over-and misused. This additional information will help to broaden their perspective when evaluating and planning the most effective diagnostic and antibiotic stewardship interventions for unique populations and settings.
As the faculty or stewardship champion leading this effort, you can decide how the content is distributed and presented to your stewards- in- training.
For Stewards - in - Training:
The fellow/trainee can watch the eLearning on their own, followed by a debrief between fellow and faculty.
To present in a classroom or small group setting, you can open the eLearning and let it talk for you, controlling the slides and the pace. You can also disable the audio and narrate the eLearning yourself.
Program Directors, Antimicrobial Stewardship Faculty Champions, and additional Faculty responsible for leading and implementing the Curriculum.
Upon completion of this section, stewards- in- training will be able to:
- Describe systematic approaches to improving antimicrobial use in the major “infection syndromes” where antimicrobials are over- and misused in both the inpatient and outpatient settings (i.e. URI, otitis media, SSTI, UTI)
- Compare and contrast the practice of Antimicrobial Stewardship in special settings and populations: Emergency Department, Long Term Care Facilities, Outpatient, Pregnancy and Critical Care, along with Immunocompromised Hosts
- Provide examples of diagnostic (laboratory) stewardship
- Compare and contrast effective antimicrobial stewardship techniques in the outpatient vs. inpatient settings
- Describe how to implement the core elements of outpatient antibiotic stewardship
- Understand successful ambulatory stewardship strategies (provider and patient- driven) such as commitment posters, delayed prescriptions, EMR best practice alerts and justification notes.
- Be familiar with resources from CDC and other organizations to assist with ambulatory ASP efforts
- Considering available resources, determine the most cost-effective and high impact interventions to implement
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
|Name||Individual's Role in Activity||Name of Commercial Interest||Nature of Relationship|
|Abbo, Lillian||Workgroup member||Pfizer Brazil||Honoraria|
|Advani, Sonali||Workgroup member||Nabriva Therapeutics||Advisory/Consultant Role|
|Amstrong, Wendy||Workgroup member||None|
|Barsoumian, Alice||Workgroup member||None|
|Beeler, Cole||Workgroup member||None|
|Bystritsky, Rachel||Workgroup member||None|
|Cherabuddi, Kartik||Workgroup member||Gatorade||Start - up Research Fund|
|NIH (Medimmune)||Research Grant|
|Cohen, Seth||Workgroup member||None|
|Hamilton, Keith||Workgroup member||None|
|Ince, Dilek||Workgroup member||Ansun Pharma||Research Grant|
|Justo, Julie Ann||Workgroup member||None|
|Luther, Vera||Workgroup member||None|
|Lynch, John||Workgroup member||Astellas Pharmaceuticals, Juno Therapeutics||Advisory/Consultant Role|
|Nori, Priya||Workgroup member||None|
|Ohl, Christopher||Workgroup member||Paratek, Bayer, Cempra Pharmaceuticals||Advisory/Consultant Role|
|Patel, Payal||Workgroup member||None|
|Pottinger, Paul||Workgroup member||McGraw Hill, Elsevier||Honoraria|
|Schwartz, Brian||Workgroup member||None|
|Spicer, Jennifer||Workgroup member||None|
|Stack, Conor||Workgroup member||None|
|Zhou, Yuan||Workgroup member||None|